Although both TRAF4 and TRAF6 showed potentially diagnostic value in differentiating active CD and UC from healthy controls, only TRAF6 could be pre-activated in non-inflamed tissue of IBD patients. This evidence concerns the gene TRAF6 and inflammatory bowel disease.